The market is driven by increased biopharmaceutical research and scaling of cell and gene therapies, with opportunities in ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment ...

Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...

Bye-bye dark circles.

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the biot | ...

Carbs have long been villainized by diet culture. But for anyone who trains regularly, skipping them might be what’s actually holding you back.

Police officers helped save the life of a man who was found slumped at the wheel of a car in "urgent need of help" on a main road in Nottingham. The man, aged in his 30s, was spotted in a car along ...

WATERBURY, Conn. (WTNH) — Many Waterbury residents still without water service are turning to local community centers to shower, while others are struggling to get bottled water. One viewer even sent ...

Karma came back for The Miz at Saturday Night's Main Event after he replaced a name in the "Last Time is Now" tournament lottery ball machine with his own in Nick Aldis' office on an episode of WWE TV ...

PHILADELPHIA (WPVI) -- A large water main break is causing some issues Friday morning in Philadelphia's Rhawnhurst section. The break was discovered on an 8-inch main on Algon Avenue, near Hoffnagle ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...

Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.